Isabella Annesi-Maesano is an expert in Pulmonology at University Hospital of Montpellier (France). As of July 2026, ScienceLeadR ranks Isabella Annesi-Maesano in the top 1% of experts worldwide for Asthma, Nose Diseases and Hypersensitivity. Isabella Annesi-Maesano has authored 668 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,721 (community average: 125). How the SLR is computed.

LeadR Profile

Isabella Annesi-Maesano University Hospital of Montpellier France
1 721 ScienceLeadR Reputation 1721
Network Map

Pulmonology

Subspecialties: Immunology - Public Health - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026

Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 668

Citations

Citations: 33 376 1st author: 48 Last author: 139 Unique author: 26


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Prenatal Smoking Exposures and Epigenome-Wide Methylation in Newborn Blood.
PMID 42428256 — research design, genes, pregnancy, blood, infant, newborn, tobacco smoking, cotinine, epigenome, environmental health, environment, smoking
Environ Health Perspect20260
Epigenetic gestational age acceleration and indicators of BMI trajectories in childhood.
PMID 42374057 — maternal age, gestational age, gestational weight gain, adiposity, natural science disciplines, child
Sci Rep20260
Occupational category, job type, and sarcoidosis: Findings from a French multicenter study.
PMID 42339517 — dust, epidemiology, sarcoidosis, phenotype, occupational exposure, occupations, workplace
Pulmonology20260
Legends of Allergology and Clinical Immunology: Gennaro D'Amato, a Pioneer in Climate Change and Respiratory Health.
PMID 41916765 — hypersensitivity, climate, immunology
Allergy20260
[The 2025 respiratory research days: A first in Caen!].
PMID 41856819 — tuberculosis, research
Rev Mal Respir20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Completed 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 34

LeadR Networks

Main global connection map